title: [Dipeptidyl peptidase 4 inhibitors and the risk of cardiovascular disease: The case of sitagliptin].
authors.affiliation: Medicina de Familia y Comunitaria, Unidad Básica de Salud Es Castell, Menorca, España; Miembro del Grupo de Diabetes de SEMERGEN. Electronic address: mseguid5@gmail.com.
authors.forename: M
authors.initials: M
authors.lastname: Seguí Díaz
mesh_terms: D002318:Cardiovascular Diseases; D003924:Diabetes Mellitus, Type 2; D054873:Dipeptidyl-Peptidase IV Inhibitors; D052216:Glucagon-Like Peptide 1; D006801:Humans; D011719:Pyrazines; D000068900:Sitagliptin Phosphate; D014230:Triazoles
chemical_list: D054873:Dipeptidyl-Peptidase IV Inhibitors; D011719:Pyrazines; D014230:Triazoles; D052216:Glucagon-Like Peptide 1; D000068900:Sitagliptin Phosphate